NASDAQ: CRVOCervomed Inc Stock Ownership - Who owns Cervomed?
Insider buying vs selling
Have Cervomed Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew Winton | Chief Commercial and Business | 2025-11-18 | 1,500 | $7.95 | $11.93kBuy |
| William Robert Elder | CFO GC Secretary | 2025-11-18 | 2,500 | $8.32 | $20.80kBuy |
| John J. Alam | CEO President | 2025-11-17 | 10,807 | $8.46 | $91.43kBuy |
| John J. Alam | CEO President | 2025-11-17 | 10,793 | $8.46 | $91.31kBuy |
| Sylvie Gregoire | Director | 2025-11-17 | 10,807 | $8.46 | $91.43kBuy |
| Matthew Winton | Chief Commercial and Business | 2025-11-17 | 3,500 | $8.43 | $29.51kBuy |
| William Robert Elder | CFO GC Secretary | 2025-11-17 | 1,000 | $8.45 | $8.45kBuy |
| Sylvie Gregoire | Director | 2025-11-17 | 10,793 | $8.46 | $91.31kBuy |
| Sylvie Gregoire | Director | 2025-11-14 | 1,707 | $7.57 | $12.92kBuy |
| John J. Alam | CEO President | 2025-11-14 | 1,693 | $7.55 | $12.78kBuy |
CRVO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRVO insiders and whales buy or sell their stock.
CRVO Shareholders
What type of owners hold Cervomed Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Paul Feller | 283.39% | 26,238,427 | $90.26M | Insider |
| Richard Baxter Gilliam | 137.04% | 12,687,975 | $43.65M | Insider |
| Ralph Feller | 100.77% | 9,329,655 | $32.09M | Insider |
| John Gainer | 40.24% | 3,725,711 | $12.82M | Insider |
| Yael Schwartz | 25.90% | 2,397,673 | $8.25M | Insider |
| Craig Abolin | 24.67% | 2,283,720 | $7.86M | Insider |
| John J. Alam | 24.07% | 2,228,617 | $7.67M | Insider |
| Sylvie Gregoire | 24.04% | 2,226,117 | $7.66M | Insider |
| David Sherris | 17.26% | 1,597,593 | $5.50M | Insider |
| Thomas E. Byrne | 15.03% | 1,391,867 | $4.79M | Insider |
CRVO vs Biotech Stocks
Cervomed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.